Travere Therapeutics
TVTX
#4650
Rank
โ‚ฌ1.38 B
Marketcap
15,56ย โ‚ฌ
Share price
5.57%
Change (1 day)
205.42%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -4,27ย โ‚ฌ

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -3,99ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,86ย โ‚ฌ a decrease over its 2021 EPS that were of -2,67ย โ‚ฌ.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,27ย โ‚ฌ10.82%
2022-3,86ย โ‚ฌ44.22%
2021-2,67ย โ‚ฌ-10.09%
2020-2,97ย โ‚ฌ-2.6%
2019-3,05ย โ‚ฌ36.22%
2018-2,24ย โ‚ฌ64.94%
2017-1,36ย โ‚ฌ20.31%
2016-1,13ย โ‚ฌ-135.46%
20153,19ย โ‚ฌ-175.68%
2014-4,21ย โ‚ฌ98.75%
2013-2,12ย โ‚ฌ1746.15%
2012-0,11ย โ‚ฌ1.34%
2011-0,11ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,88ย โ‚ฌ-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,24ย โ‚ฌ-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA